• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

The Market Outlook for the Week Ahead, or The Recession Trade is On

Diary, Newsletter

Any doubts that financial markets are fully discounting a recession were completely smashed last week.

It isn’t just the economic data that are rolling over like the Bismarck. Oil plunged 19%, copper is off 22% from its top, and bond yields have collapsed an astonishing 46 bases points in only two weeks, from 3.48% to 3.02%, a cataclysmic move in the bond market.

Asset classes most sensitive to a recession, like industrial commodities, suffered the biggest falls. That’s because if commodities don’t get used immediately they have to be stored at great expense and a million barrels of oil don’t look very pleasant in your backyard.

How did the stock market respond? It loved it. Stocks delivered the first positive week in June. The Dow Average rallied a healthy 1,900 points off the bottom, some 6.41%.

So what gives? Why is every asset class in the world getting trashed while stocks rocket?

It's really very simple. Stocks love lower interest rates. Cut borrowing costs and equities catch a bid. Lower rates more and stocks should further appreciate.

It's not like we are out of the woods yet. We could get another interest rate spike as we move into the next Fed move on interest rates on July 27. That could take us to new lows in stocks, but not by much. Any declines from here will be limited and are worth buying, as I have been arguing for weeks.

Always focus on what is going to happen next for we are in the “what happens next business.”

While broker reports, research, and the news focus on what happened in the past, or rarely today, it is what happens next that determines the performance of your investment portfolio.

Live in the future and there are never any surprises, only rewards.

Powell
Highlights the Fed’s Inflation Commitment, even though the principal drivers, OPEX+ and the Ukraine War, are completely out of his control, in testimony in front of congress. The next two 75 basis point rate rises are a sure thing. Number three won’t happen if a recession kicks in before then.

Oil Dives as Recession Fears Mount, off 20% in a week. Oil is the last thing you want to hold going into a recession, as storage fears are at record highs a few tankers are available for charter. Avoid all energy plays like the plague. Too many other better fish to fry.

American Airlines, United Airlines, and Delta are Cutting Routes, to deal with staff shortages. Small cities where no money is made, like Toledo, Islip, and Dubuque are the main targets. Reno lost much of its airline services in the last recession for the same reason.

A Real Estate Selloff is Going Global, the effect of rising interest rates worldwide. Auckland, New Zealand, Vancouver, Canada, and Sydney, Australia have suddenly seen homes go heavily offered as free money disappears. The US could be next. In Incline Village, NV homes priced under $1 million are seeing aggressive price cuts to sell, while those over $5 million are maintaining prices.

Electric Vehicles Could Reach a 33% Market Share by 2028 and 54% by 2035, says AlixPartners, a research firm. Automakers are going to have to invest $526 billion to meet this demand. EVs are becoming a dominant factor in the US economy. Keep buying (TSLA) on dips, which has a 12-year head start over everyone and has an 80% global EV market share. You just missed a chance to buy the shares at $635 last week.

Existing Home Sales plunge 3.4% in May to 5.41 million units, Dow 8.6% YOY. Inventories fell slightly, with 1.16 million homes for sale. The median home price rose to a new all-time high of $407,600. Home sales priced under $250,000 are down 27% YOY. Mansions are still selling well nationally.

Industrial Production rises by a modest 0.2% in May. Their recession hasn’t hit here yet.

Bitcoin hit a $17,900 low Asian trading. Bitcoin crash is particularly compelling to watch as it has become a great risk indicator for all asset classes. Ignore it at your peril. It turns out that the wonder of 24/7 trading means it can go down a lot faster. I have no idea where the bottom is so don’t ask. This amount of fear is impossible to quantify.

My Ten-Year View

When we come out the other side of pandemic and the recession, we will be perfectly poised to launch into my new American Golden Age, or the next Roaring Twenties. With oil peaking out soon, and technology hyper-accelerating, there will be no reason not to. The Dow Average will rise by 800% to 240,000 or more in the coming decade. The America coming out the other side will be far more efficient and profitable than the old. Dow 240,000 here we come!

With some of the greatest market volatility in market history, my June month-to-date performance exploded to +9.99%.

My 2022 year-to-date performance ballooned to 51.86%, a new high. The Dow Average is down -13.22% so far in 2022. It is the greatest outperformance on an index since Mad Hedge Fund Trader started 14 years ago. My trailing one-year return maintains a sky-high 73.27%.

That brings my 14-year total return to 564.42%, some 2.56 times the S&P 500 (SPX) over the same period and a new all-time high. My average annualized return has ratcheted up to 44.85%, easily the highest in the industry.

We need to keep an eye on the number of US Coronavirus cases at 87 million, up 300,000 in a week and deaths topping 1,016,000 and have only increased by 2,000 in the past week. You can find the data here.

On Monday, June 27 at 8:30 AM, US Durable Goods for May are released.

On Tuesday, June 28 at 7:00 AM, the S&P Case Shiller National Home Price Index for April is out.

On Wednesday, June 29 at 7:00 AM, the final read of the US Q1 GDP is published.

On Thursday, June 30 at 8:30 AM, Weekly Jobless Claims are announced. We also get US personal Income & Spending.

On Friday, July 1 at 7:00 AM, the ISM Manufacturing PMI for June is disclosed. At 2:00 the Baker Hughes Oil Rig Count is out.

As for me, as this pandemic winds down, I am reminded of a previous one in which I played a role in ending.

After a 30-year effort, the World Health organization was on the verge of wiping out smallpox, a scourge that had been ravaging the human race since its beginning. I have seen Egyptian mummies at the Museum of Cairo that showed the scarring that is the telltale evidence of smallpox, which is fatal in 50% of cases.

By the early 1970s, the dreaded disease was almost gone but still remained in some of the most remote parts of the world. So, they offered a reward to anyone who could find live cases.

To join the American Bicentennial Mt. Everest Expedition in 1976, I took a bus to the eastern edge of Katmandu and started walking. That was the farthest roads went in those days. It was only 150 miles to basecamp and a climb of 14,000 feet.

Some 100 miles in, I was hiking through a remote village, which was a page out of the 14th century, back when families though buckets of sewage into the street. The trail was lined with mud brick two-story homes with wood shingle roofs, with the second story overhanging the first.

As I entered the town, every child ran to their windows to wave, as visitors were so rare. Every smiling face was covered with healing but still bleeding smallpox sores. I was immune, since I received my childhood vaccination, but I kept walking.

Two months later, I returned to Katmandu and wrote to the WHO headquarters in Geneva about the location of the outbreak. A year later I received a letter of thanks at my California address and a check for $100. They told me they had sent in a team to my valley in Nepal and vaccinated the entire population.

Some 15 years later, while on customer calls in Geneva for Morgan Stanley, I stopped by the WHO to visit a scientist I went the school with. It turned out I had become quite famous, as my smallpox cases in Nepal were the last ever discovered.

The WHO certified the world free of smallpox in 1980. The US stopped vaccinating children for smallpox in 1972, as the risks outweighed the reward.

Today, smallpox samples only exist at the CDC in Atlanta frozen in liquid nitrogen at minus 346 degrees Fahrenheit in a high-security level 5 biohazard storage facility. China and Russia probably have the same.

That’s because scientists fear that terrorists might dig up the bodies of some British sailors who were known to have died of smallpox in the 19th century and were buried on the north coast of Greenland, remaining frozen ever since. If you need a new smallpox vaccine, you have to start from somewhere.

As for me, I am now part of the 34% of Americans who remain immune to the disease. I’m glad I could play my own small part in ending it.

Stay healthy,

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

On Mt. Everest Smallpox Free in 1976

 

 

 

 

 

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-27 09:02:082022-06-27 17:44:13The Market Outlook for the Week Ahead, or The Recession Trade is On
Mad Hedge Fund Trader

June 24, 2022

Tech Letter

Mad Hedge Technology Letter
June 24, 2022
Fiat Lux

Featured Trade:

(GETTING REAL WITH HOME-SHARING TECH)
(ABNB)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-24 15:04:382022-06-24 15:32:25June 24, 2022
Mad Hedge Fund Trader

Getting Real With Home-Sharing Tech

Tech Letter

Airbnb’s (ABNB) stock has about halved from $206 at the tech market peak of 2021 to around $100 today.

The strength in the first half of 2021 resulted from the optimism coalescing in travel circles about the reverse of shelter-at-home lifestyle to unfettered international travel.

Remember back then, increasingly more countries were allowing Americans into their land with proof of 2 Pfizer shots.

The $130 to $206 rise was simple an overshoot.

Sentiment was at a generational low during 2020 and the upside was merely a result of the extreme reverse of great pessimism to ultra-optimism.

At a micro level, Airbnb’s business model mirrored the same sentiment of the 2020 tsunami of travel cancellations.

Bad optics has been a staple for CEO Brian Chesky.

Then the onslaught of arbitrary refunds to customers alienated the Airbnb host.

They slowly changed their policy to remove “extenuating circumstances” as a reason to get a full refund.

It wasn’t that I had a problem with Airbnb going to $206.

Like many tech growth stocks, they tend to go parabolic during good times.  

Tech firms with better balance sheets haven’t halved in value like Airbnb.

That being said, Airbnb is not worth the current $60 billion and a 74 P/E ratio is too expensive at a fundamental level.

After halving, I still think the valuation is a tad bit too generous.

I believe the company is worth $60 billion only if interest rates are close to zero and not the 3.1% we have today on the 10-year US treasury.

The company is worth significantly less in its current form in 2022 and as rates accelerate from 3.1% to 3.5 or 4%, I expect the company to be worth $45 billion.

On the demand side, travel is a lot more expensive now than ever.

I am not only talking about airfare, but also airport car transfers, price for baggage, entertainment, food, and accommodation which are all trending above 40%-80% depending on the item in tourist areas.

However, Americans are making summer of 2022 the “revenge” trip of a lifetime.

The pre-pandemic overtones of fear of missing out (FOMO) and you only live once (YOLO) are back stronger than ever on short-form video platforms like TikTok and Instagram.

One might believe Airbnb stock should be cruising on auto pilot, right?

Well, the revenge travel of summer 2022 is already baked into the price of the stock since this behavior was largely understood 6-8 months before.

The drop in shares has to do more with the lack of incremental demand that will follow the summer of 2022 as the US barrels towards a recession.

Yes, travel will decelerate fast after summer 2022 as Americans blow their load while failing to reload for the 2nd half of 2022.

This is awful news for Airbnb stock.

Another element is gas prices.

The cost of gas and groceries is about to explode as Americans need to fill up their tank and buy groceries for Independence Day celebrations all in unison.

The pitiful energy infrastructure that has been gutted by the current administration won’t be able to handle the elevated demand.

This will 100% limit the budget of Airbnb for Americans.

Airbnb posted an average daily rate (ADR) of $168.46 in Q1, up 5.3% YoY.

However, its growth has decelerated from previous quarters and I expect it to fall even more later this year.  

Until we capitulate, the downtrend likely won’t reverse because the business model isn’t that bad and they do boast a monopoly.

 

airbnb stock

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-24 15:02:372022-06-25 18:05:07Getting Real With Home-Sharing Tech
Mad Hedge Fund Trader

Quote of the Day - June 24, 2022

Tech Letter

“Life is too short for long-term grudges.” – Said CEO and Founder of Tesla Elon Musk

 

https://www.madhedgefundtrader.com/wp-content/uploads/2021/01/elon-musk2.png 238 280 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-24 15:00:372022-06-24 15:26:45Quote of the Day - June 24, 2022
Mad Hedge Fund Trader

June 24, 2022

Diary, Newsletter, Summary

Global Market Comments
June 24, 2022
Fiat Lux

Featured Trade:

(TAKING OFF FOR THE 2022 MAD HEDGE WORLD TOUR)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-24 09:04:172022-06-27 12:24:26June 24, 2022
Mad Hedge Fund Trader

Taking Off for the 2022 Mad Hedge World Tour

Diary, Newsletter

By the time you read this, I will be on a Lockheed C5 A Galaxy escorting 100 Javelin missiles to RAF Lakenheath in England.

From there, I have no idea where the anti-tank missiles are headed. The largest plane in the US Air Force won’t offer the comfortable first class accommodations that I’m used to. But I can’t argue with the price: it’s free.

It was only weeks ago that I received an early morning phone call from a familiar number in Washington DC. At age 70, I was expecting to get a mandatory retirement and a “Job well done.”

Not for me.

Instead, I received a promotion to Major in the United States Marine Corps and was asked how soon could I get to North Atlantic Treaty Organization headquarters in Brussels, Belgium? I answered, “As soon as I get rid of this Covid thing.”

It turns out that suddenly, so many people now want to be America’s friends that we have a shortage of senior people on our side to meet them. So senior people like me all over the country are getting called up and pressed into duty.

Instead of fine dining in London and the best wurst and wines in Switzerland, I’m going to be eating army food for my summer vacation. At least it will be French army food. That has to be some kind of improvement.

I will be expounding on my global view to the top generals at NATO. I’ll outline the long-term consequences of the Ukraine War. I’ll also be meeting with individual NATO members as well as future potential ones.

I still hope to eventually end up at my chalet in Zermatt, Switzerland where I traditionally restart my year and have not visited in three years. Weather permitting, I will climb the 14,692-foot Matterhorn again. Is it seven times this year, or eight?

Otherwise, I’ll rejoin Zermatt Search and Rescue again visiting old friends and pulling lost Americans off of Alpine slopes. It seems I’m the only one up there who has a sense of humor.

I have worked the hardest in my life the past year, and it is time for a break. I have also put myself through the most grueling training regimen ever, hiking 2,000 miles in torrential rains and snowshoeing another 600, all with a 50-pound pack. Covid took a lot out of me.

Every year, it seems to get harder to keep the calendar at bay.

Getting out into the real world and soaking up new data and opinions is invaluable in shaping my own global view, and your performance benefits from it.

I will be traveling with my laptop and keeping touch with the markets. While 18th century Internet service is passable, the bandwidth can be snail-like. So, unless I see something extraordinary, I will cut back on new Trade Alerts.

After running up a 50% profit so far in 2022, I deserve a break. I am risking over trading. I need to spend some time alone on a mountaintop, communing with the spirits, attempting to discover the new long-term market trends through the mist.

While on the road, I will continue writing my newsletter, giving you my daily dose of market insight. I will also be re-running some of my favorite research pieces from the past when my travel schedule does not allow Internet access.

This is to expose my thousands of new subscribers to the golden oldies, and to remind the legacy readers who have since forgotten them.

I will be back in San Francisco in early August, glued to my screens once again for another year of toil in the salt mines. In the meantime, please feel free to email me.

Mad Hedge Technology Letter author Arthur Henry will be working straight through the summer. No rest for the wicked!

In the meantime, I shall be raising a glass to all of you at dinner, the loyal readers of The Diary of a Mad Hedge Fund Trader. Salute! Prost! Kampai, and Cheers! Thanks for making this letter a huge success!

If you want to take the opportunity to meet me in person, please find my strategy luncheon schedule below. To purchase tickets for the luncheons, please go to my online store and click on the country and city of your choice.

Wednesday, June 29, 12:00 PM London, England
Friday, July 22, 3:00 PM Zermatt, Switzerland
Thursday, July 28, 12:00 PM Venice Italy

I look forward to seeing you there, and thanks for supporting my research.

John Thomas
CEO & Publisher
Diary of a Mad Hedge Fund Trader

 

 

 

Now Which One of These is for Belgium?

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-24 09:02:302022-06-24 15:12:30Taking Off for the 2022 Mad Hedge World Tour
Mad Hedge Fund Trader

June 23, 2022

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
June 23, 2022
Fiat Lux

Featured Trade:

(AN A-RATED STOCK FOR THE ANXIOUS INVESTOR)
(PFE), (AZN), (MRK), (NVO), (BNTX), (VLA), (GSK)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-23 17:02:012022-06-23 21:47:25June 23, 2022
Mad Hedge Fund Trader

An A-Rated Stock for the Anxious Investor

Biotech Letter

Choosing businesses with size and scale in their favor is more often than not a wise move for investors.

After all, these companies tend to be well established in their respective fields and hold a higher chance than their peers in terms of sticking around for a long time.

Pfizer (PFE) is an excellent example of a mature biopharmaceutical stock that could efficiently deliver great rewards to investors for many years.

However, the elephant in the room for this stock is whether the bumper profits from its COVID-19 vaccines will be sustained in the long term. These concerns have kept a lid regarding the company’s valuation.

If we strip out Comirnaty from the conversation, Pfizer will still have a decent valuation in relation to its share price today.

It has a current P/E of 11x and market capitalization to operating cash flows of 8.9x. In contrast, fellow vaccine maker AstraZeneca (AZN) has been trading at a negative P/E and a stressful market cap to operating cash flow of 27 times.

For added context, Big Pharma names Merck (MRK)’s P/E is 17x while Novo Nordisk (NVO) has been trading 37 times.

Going back to Pfizer, the company’s first-quarter earnings results for 2022 indicated a strong performance and reinforced its guidance this year.

For the full year of 2022, the company projects sales within the range of $98 billion to $102 billion.

To offer you a better picture of the scale of this growth, this would amount to 150% times the yearly sales between 2018 and 2020

It would actually be a quarter higher than the 2019 and 2020 sales combined.

If this roughly $100 billion forecast is achieved, Pfizer will become the first-ever pharmaceutical stock to reach that goal.

To put this in perspective, if we consider Pfizer as a country or a territory, then its GDP would be ranked 64th globally.

This would put it above Ethiopia and immediately behind Puerto Rico.

During this period, Pfizer recorded $25.7 billion in revenue, showing off an impressive 82% operational growth rate year-over-year and a 76% EPS growth.

Comirnaty, co-created with BioNTech (BNTX), raked in $13.2 billion, reporting a 282.1% spike for Pfizer

Meanwhile, the newly launched COVID-19 treatment, Paxlovid, generated $1.5 billion in revenue.

Pfizer’s consistent exponential growth, as shown in the first-quarter earnings, isn’t solely dependent on its COVID vaccines.

While Comirnaty and Paxlovid comprised over 50% of the $25 billion revenue in that period, sales from other segments continued to rise.

For example, stroke and blood clot treatment Eliquis generated $1.8 billion, up by 12% from its 2021 first-quarter sales of $1.2 billion. Meanwhile, heart failure treatment Vyndamax jumped by an impressive 41% to hit $612 million.

On top of its solid drug development pipeline, Pfizer has been leveraging its bumper cash flow to pursue bolt-on acquisitions of promising biopharmas.

Just last month, Pfizer acquired Biohaven Pharmaceuticals for $11.6 billion in cash. The smaller company’s primary treatment is Rimegepant, a migraine medication approved in both the US and Europe.

Aside from that, Pfizer threw its weight behind a fellow COVID vaccine maker, a French biotechnology company called Valneva (VLA).

Valneva’s most promising program is its late-stage development of a vaccine for Lyme disease.

When Pfizer announced its decision to add $95.6 million to the project plus up to $100 million in milestone payments, it triggered a massive 81% surge in Valneva stock price.

Pfizer and Valneva’s partnership for developing a Lyme disease vaccine started in 2020 when the bigger biopharma paid $130 million upfront.

This latest revision of their deal will not only up Pfizer’s stake in Valneva to 8.1% but also allow the French biotech to continue with its Phase 3 trial without the fear of straining its cash position.

Pfizer currently holds a distinct position in its history, with gushers of cash coming practically from all places.

These sums can only be expected to go higher with the anticipated listing of its consumer healthcare business, which it co-owns with GlaxoSmithKline (GSK). While there’s no official word yet on the deal, Pfizer’s plan to sell its stake could generate roughly $19 billion.

Moreover, the company maintains a respectable dividend yield of 3% and a net debt of roughly $10 billion, which can be completely paid off using its operating cashflows for three to four months.

This enables Pfizer to sustain a comfortable credit rating of “A” Stable from Fitch, thereby making it financially stable and safe from the ever-increasing interest rates.

Needless to say, Pfizer is the kind of stock that offers rare stability in this turbulent period.

 

pfizer stock

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-23 17:00:572022-06-24 14:50:44An A-Rated Stock for the Anxious Investor
Mad Hedge Fund Trader

June 23, 2022

Bitcoin Letter

Mad Hedge Bitcoin Letter
June 23, 2022
Fiat Lux

Featured Trade:

(EASIEST WAY TO SHORT BITCOIN)
(BTC), (BITI)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-23 16:04:332022-06-23 21:48:53June 23, 2022
Mad Hedge Fund Trader

Easiest Way to Short Bitcoin

Bitcoin Letter

The ticker symbol is BITI – write it down in your journal.

What’s that?

That’s the new ProShares Short Bitcoin ETF that just started trading on the New York Stock Exchange 2 days ago.

It’s been a long time coming.

Crypto ETFs have had an arduous journey to finally join other assets trading publicly.

Handcuffed by regulation behind the scenes, crypto has been roadblocked.

The really underscored the enormity of situation and how difficult it is to get approved in America, much like building an oil refinery in the United States.

It only took eight months after first creating the initial U.S. bitcoin futures ETF.

What does this mean?

Instead of executing some type of exotic trade exposing an investor to a short Bitcoin position on some alternative market, investors can now just click and buy a product that bets against an appreciating price of Bitcoin.

In short, if Bitcoin goes down, profit is accrued.

This makes it even easier to hate crypto if the gateways to bet against it have enlarged.

Before this, the best way to really expose oneself in an insured marketplace was to sell short MicroStrategy (MSTR).

However, MSTR never correlated 1:1 with Bitcoin and it was something closer to 85% correction.

The fall to $17,000 for Bitcoin means that it has not participated in the latest bear market rally but only participated in the selloffs.

That’s never something you want to hear if you are interested in buying into an asset class.

Considering that traditional brokerage accounts can now bet against Bitcoin will result in more short sellers and not less.

BITI will be the first ETF of its kind in the U.S. Horizons ETFs has a short bitcoin ETF listed on the Toronto Stock Exchange.

ProShares said BITI is designed to deliver the opposite of the performance of the S&P CME Bitcoin Futures Index and that it seeks to obtain exposure through bitcoin futures contracts.

How well-timed the launch remains to be seen? Markets remain fraught with uncertainty, and I do believe Bitcoin will trend towards $12,000 per coin in the short-term.

I know there's a ton of people who had massive FOMO from missing the rise of Bitcoin and they have been even happier that they missed the elevator down as well.  

I've taken calls from friends and even family asking if they should buy the dip and the answer is no.

Bitcoin is bereft of dip buyers as small and large buyers have gone AWOL for different reasons.

Much of the new incremental capital has gone into shorting interest rates and buying commodities.

Other institutional capital like Ray Dalio’s Bridgewater hedge fund just doubled their bet against Europeans stocks to $10.5 billion.

Bitcoin, as it exists in its current form, just isn’t attractive to the incremental buyer.

As Bitcoin gets cheaper, one might say it’s on sale, but sales can be lowered and that’s the path of least resistance unless something changes.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2022-06-23 16:02:142022-06-23 21:50:30Easiest Way to Short Bitcoin
Page 3 of 15‹12345›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top